Risk factor
Negligible price volatility
Profitability factor
Weak margins and returns
About
Tessenderlo Group N.V., a global entity established in 1919 and headquartered in Brussels, Belgium, is a subsidiary of Verbrugge NV. The company, which rebranded from Tessenderlo Chemie nv in June 2017, operates across four principal segments: Agro, Bio-Valorization, Industrial Solutions, and T-Power, serving diverse end markets such as agriculture, food, industry, construction, health, and consumer goods. The Agro division is dedicated to the manufacturing, marketing, and distribution of essential crop nutrients, including liquid and potassium sulfate fertilizers sold under brands like Thio-Sul, KTS, K-Row 23, CaTs, GranuPotasse, SoluPotasse, and K-Leaf. Additionally, it provides crop protection products such as LINEX and VELPAR herbicides, SEVIN insecticide, and SECTAGON fumigant. Through its Bio-Valorization segment, Tessenderlo Group transforms bio-residuals into a range of valuable products like gelatins, collagen peptides, proteins, and fats. These are supplied to various sectors, including food, pharmaceutical, health and nutrition, pet food, agriculture, aqua feed, animal feed, energy, biodiesel, oleo-chemistry, and sanitary markets. The Industrial Solutions arm manufactures and supplies plastic pipe systems and chemicals for water treatment. This segment also encompasses other industrial activities, including the production and sale of mining and industrial auxiliaries, alongside specialized services for treating and disposing of produced and flowback water from oil and gas exploration, and recovering industrial process fluids. Finally, the T-Power segment focuses on energy generation, utilizing a 425 MW combined cycle gas turbine to produce electricity.
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, undervalued on E
Target Price
The average target price of TESB.BR is 24.4 and suggests 21.5% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i